Levodopa/Benserazide Orifarm

Levodopa/Benserazide, the active ingredient in Levodopa/Benserazide Orifarm, is a Levodopa/benserazide combination presented as an oral tablet for oral use. It is employed to manage motor symptoms of Parkinson's disease in adult patients. GNH USA supplies Levodopa/Benserazide Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Benserazide is used within the antiparkinson therapeutic pathway to improve dopaminergic activity. - Parkinson's disease: reduces bradykinesia, rigidity and tremor, improving motor function. - Parkinsonian syndrome: alleviates motor deficits associated with secondary Parkinsonism. - Rest tremor: diminishes amplitude and frequency of resting tremor in affected individuals.

Levodopa/Benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional emesis, especially after dose initiation. - Dizziness: often related to orthostatic changes. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating or maintaining sleep.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory perceptual disturbances. - Severe hypotension: marked blood pressure reduction requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms in susceptible patients. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe psychiatric symptoms: agitation, confusion or psychosis.

When prescribing Levodopa/Benserazide, clinicians should consider several safety measures. - Dose titration: start low and increase gradually to minimize adverse effects. - Monitor blood pressure: watch for orthostatic hypotension, especially in the elderly. - Assess psychiatric status: the drug may exacerbate hallucinations or confusion. - Avoid abrupt discontinuation: sudden stop can lead to withdrawal and worsening of Parkinsonian signs. - Use with caution in renal or hepatic impairment: adjust therapy based on organ function. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levodopa/Benserazide interacts with several medicines that can alter its efficacy or safety.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): antagonize dopamine effect, reducing therapeutic benefit. - Pyridoxine (vitamin B6): enhances peripheral decarboxylation, decreasing central levodopa levels. - High‑protein meals: compete for intestinal transport, lowering levodopa absorption. - Iron or calcium supplements: chelate levodopa, reducing bioavailability.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive hypotensive effect may require dose adjustment. - SSRIs or SNRIs: potential for serotonin syndrome when combined with MAO‑B inhibitors. - Diuretics: may affect electrolyte balance, influencing blood pressure control.